CLINICAL_TRIALS
trial_result
· 2014-04-24
Clinical Trial Update: REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) [Phase 4]
Summary
Phase 4 trial REPArE evaluated etanercept (Enbrel) for psoriatic arthritis; the study has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-04-24